| abstract |
Disclosed is an agent for treatment and/or prevention of hematopoietic tumor which contains a thiadiazoline derivative represented by the general formula (I) below or a pharmacologically acceptable salt thereof. [In the formula, n represents an integer of 1-3; R1 represents a hydrogen atom and R2 represents a lower alkyl, or alternatively R1 and R2 combine together to form an alkylene; R3 represents a lower alkyl; R4 represents NHSO2R6 (wherein R6 represents a hydroxy or the like) or the like; and R5 represents an aryl or the like.] |